Search

everythinglearnresearchcommunity

for

Search:↓

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Acne is common in adult women, often continues from adolescence, and can lead to scarring.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Umbilical cord blood transplantation improved the boy's symptoms despite complications.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

A young tapir with a rare skin condition improved after treatment with wound cleaning, cream, and oral medication.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Using minoxidil with finasteride in a cream helps maintain hair thickness after stopping oral finasteride.

Lichen planus pigmentosus may indicate undetected hepatitis C infection.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

Topical finasteride cream reduces hair growth perception in women with idiopathic hirsutism.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

A targetoid hair regrowth pattern indicates recovery in alopecia areata.

Terbinafine can cause skin reactions when exposed to sunlight, so sun exposure should be avoided during treatment.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Alopecia areata in Taif is common, mainly immune-related, and best treated with topical corticosteroids and vitamins.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Alopecia areata incognita causes sudden hair loss but usually improves with topical steroids.

AKN is a chronic scalp condition in African-descended males, treated with topicals, antibiotics, steroids, and sometimes surgery or laser.

Hormonal therapy in adults with gender dysphoria often leads to skin issues like acne, requiring a team of skin and hormone doctors.

Permanent makeup can cause delayed allergic reactions, but they can be managed with proper treatment.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.